# Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors

> **NCT01831076** · PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 36 (actual)

## Conditions studied

- Breast Cancer
- Stage II Breast Cancer
- Stage III Breast Cancer

## Interventions

- **DRUG:** Exemestane
- **DRUG:** Exemestane and tamoxifen

## Key facts

- **NCT ID:** NCT01831076
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** 2013-02
- **Final completion:** 2022-01-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2022-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01831076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01831076, "Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01831076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*